Dover
DOV NYSE Industrial Machinery & Supplies & Components Financials FY2016βFY2025
Dover's revenue rose 4.5% to $8.1 billion in fiscal 2025. Its operating margin was 17.0%, up from 15.6% a year earlier. Free cash flow was $1.1 billion, up 21.4%. It paid out $824 million in dividends and buybacks, 74% of free cash flow. The diluted share count fell 0.7%.
What Dover does
No business description yet.
- Legal name
- DOVER Corp
- Fiscal year ends
- December 31, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0000029905-26-000009
0000029905
Revenue and margins
Dover had $8.1B of revenue in fiscal 2025, up 4.5% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 10.4% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $1.1B in fiscal 2025, 13.8% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Dover returned $824M to shareholders in fiscal 2025, 74% of free cash flow. The diluted share count fell 0.7%.
Value Dover yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β$2.4B and divides by 137.8M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 23.2x Β· peers 26.2x Β· sector 26.0x.
Balance sheet
Cash, debt and the ratios that show how comfortably Dover can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $386M | $381M | $399M | $1.8B | $1.7B |
| Debt incl. finance leases | $3.0B | $3.7B | $3.5B | $3.3B | $4.0B |
| Net debt / EBITDA | 1.7x | 2.1x | 2.0x | 1.0x | 1.4x |
| Debt / equity | 0.7x | 0.9x | 0.7x | 0.5x | 0.6x |
| Interest coverage | 12.1x | 11.0x | 9.3x | 9.2x | 12.5x |
| Current ratio | 1.4x | 1.2x | 1.4x | 2.0x | 1.8x |
| Quick ratio | 0.8x | 0.7x | 0.9x | 1.5x | 1.3x |
| Total assets | $10.4B | $10.9B | $11.3B | $12.5B | $13.4B |
| Total liabilities | $6.2B | $6.6B | $6.2B | $5.6B | $6.0B |
| Shareholders' equity | $4.2B | $4.3B | $5.1B | $7.0B | $7.4B |
| Net debt (β = net cash) | $2.6B | $3.3B | $3.1B | $1.5B | $2.4B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$20.0M
4 insiders
Of sales under plans
0%
$0.0M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Feb 19, 2026 | Richard J TobinChairman, President & CEO | Sold | 76,997 | $232.70 | $17.9M | Form 4 |
| Feb 17, 2026 | Ivonne M CabreraSVP, General Counsel & Secr. | Sold | 4,000 | $233.23 | $0.9M | Form 4 |
| Feb 11, 2026 | Girish JunejaSenior VP & CDO | Sold | 1,500 | $230.77 | $0.3M | Form 4 |
| Dec 4, 2025 | Ivonne M CabreraSVP, General Counsel & Secr. | Sold | 2,630 | $190.80 | $0.5M | Form 4 |
| Nov 28, 2025 | Christopher B. WoenkerSenior VP & CFO | Sold | 1,627 | $186.05 | $0.3M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 7 / 9 | 7 / 9 | 5 / 9 |
| Accruals ratio | β2.5% | 13.5% | β1.9% |
| Altman Z'' | 5.30 | 6.66 | 6.41 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Dover DOV | $26.9B | 4.5% | 17.0% | 13.8% | 12.0% | 23.2x | 5 | |
| Ingersoll Rand IR | $28.8B | 5.8% | 15.0% | 16.0% | 6.5% | 30.2x | 5 | Compare β |
| Xylem XYL | $25.7B | 5.5% | 13.5% | 10.1% | 8.1% | 25.9x | 6 | Compare β |
| Hubbell HUBB | $23.9B | 3.8% | 20.7% | 15.0% | 18.7% | 26.5x | 7 | Compare β |
| Snap-on SNA | $18.7B | 0.9% | 25.8% | 19.5% | 19.2% | 18.6x | 6 | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $6.0B | $6.8B | $7.0B | $7.1B | $6.7B | $7.9B | $7.8B | $7.7B | $7.7B | $8.1B |
| Gross profit | $2.2B | $2.5B | $2.6B | $2.6B | $2.5B | $3.0B | $2.9B | $2.9B | $3.0B | $3.2B |
| Research and development | $116M | $131M | $143M | $141M | $142M | $158M | $151M | $139M | $150M | $165M |
| Operating income | $709M | $807M | $843M | $975M | $933M | $1.3B | $1.3B | $1.2B | $1.2B | $1.4B |
| Interest expense | $136M | $145M | $131M | $126M | $112M | $106M | $117M | $131M | $131M | $110M |
| Pretax income | $685M | $876M | $725M | $843M | $842M | $1.4B | $1.2B | $1.1B | $1.8B | $1.4B |
| Income tax | $183M | $129M | $134M | $165M | $158M | $277M | $200M | $179M | $357M | $277M |
| Net income | $509M | $812M | $570M | $678M | $684M | $1.1B | $1.1B | $1.1B | $2.7B | $1.1B |
| Diluted EPS | $3.25 | $5.15 | $3.75 | $4.61 | $4.70 | $7.74 | $7.42 | $7.52 | $19.45 | $7.94 |
| Diluted shares | 0.16B | 0.16B | 0.15B | 0.15B | 0.15B | 0.15B | 0.14B | 0.14B | 0.14B | 0.14B |
| Cash flow | ||||||||||
| Cash from operations | $735M | $739M | $789M | $945M | $1.1B | $1.1B | $806M | $1.3B | $1.1B | $1.3B |
| Capital expenditure | $140M | $170M | $171M | $187M | $166M | $172M | $211M | $183M | $168M | $220M |
| Free cash flow | $595M | $569M | $618M | $759M | $939M | $944M | $595M | $1.2B | $920M | $1.1B |
| Depreciation and amortization | $250M | $283M | $283M | $272M | $279M | $290M | $296M | $305M | $338M | $380M |
| Stock-based compensation | $18.6M | $24.1M | $23.7M | $29.7M | $25.0M | $31.1M | $30.1M | $30.8M | $40.4M | $44.0M |
| Acquisitions | $1.6B | $27.2M | $68.6M | $216M | $336M | $1.1B | $313M | $534M | $635M | $663M |
| Share buybacks | $0.0M | $105M | $895M | $143M | $106M | $21.6M | $585M | $0.0M | $500M | $541M |
| Dividends paid | $268M | $284M | $284M | $282M | $284M | $287M | $288M | $284M | $283M | $283M |
| Dividends and buybacks | $268M | $389M | $1.2B | $425M | $391M | $309M | $873M | $284M | $783M | $824M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $349M | $754M | $396M | $397M | $513M | $386M | $381M | $399M | $1.8B | $1.7B |
| Total debt | $3.2B | $3.7B | $2.9B | $3.1B | $3.1B | $3.0B | $3.7B | $3.5B | $3.3B | $4.0B |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $9.9M | $11.3M | $9.2M | $8.7M | $9.0M | $9.1M | $9.6M |
| Current assets | $2.6B | $2.8B | $2.5B | $2.5B | $2.6B | $3.1B | $3.4B | $3.4B | $4.5B | $4.5B |
| Current liabilities | $1.9B | $2.1B | $1.8B | $1.7B | $1.7B | $2.3B | $2.8B | $2.4B | $2.2B | $2.5B |
| Inventory | $871M | $677M | $749M | $806M | $836M | $1.2B | $1.4B | $1.1B | $1.1B | $1.3B |
| Property and equipment, net | $946M | $788M | $807M | $842M | $897M | $957M | $1.0B | $979M | $988M | $1.1B |
| Total assets | $10.1B | $10.7B | $8.4B | $8.7B | $9.2B | $10.4B | $10.9B | $11.3B | $12.5B | $13.4B |
| Total liabilities | $6.3B | $6.3B | $5.6B | $5.6B | $5.8B | $6.2B | $6.6B | $6.2B | $5.6B | $6.0B |
| Shareholders' equity | $3.8B | $4.4B | $2.8B | $3.0B | $3.4B | $4.2B | $4.3B | $5.1B | $7.0B | $7.4B |
| Margins | ||||||||||
| Gross margin | 36.9% | 37.1% | 36.6% | 36.7% | 37.0% | 37.6% | 37.0% | 37.3% | 38.2% | 39.8% |
| Operating margin | 11.7% | 11.8% | 12.1% | 13.7% | 14.0% | 16.2% | 16.3% | 15.9% | 15.6% | 17.0% |
| EBITDA margin | 15.9% | 16.0% | 16.1% | 17.5% | 18.1% | 19.9% | 20.1% | 19.8% | 19.9% | 21.7% |
| Net margin | 8.4% | 11.9% | 8.2% | 9.5% | 10.2% | 14.2% | 13.6% | 13.8% | 34.8% | 13.5% |
| FCF margin | 9.9% | 8.4% | 8.8% | 10.6% | 14.1% | 11.9% | 7.6% | 15.0% | 11.9% | 13.8% |
| Returns | ||||||||||
| Return on capital | 8.2% | 9.8% | 10.9% | 14.2% | 12.9% | 16.0% | 14.8% | 13.0% | 11.6% | 12.0% |
| Return on capital employed | 9.2% | 9.7% | 11.2% | 14.5% | 13.0% | 16.5% | 15.7% | 14.3% | 12.5% | 13.0% |
| Return on equity | 13.7% | 19.8% | 16.0% | 23.4% | 21.3% | 29.7% | 25.1% | 22.5% | 44.7% | 15.2% |
| Return on assets | 5.4% | 7.8% | 6.0% | 8.0% | 7.7% | 11.5% | 10.0% | 9.5% | 22.6% | 8.4% |
| Growth | ||||||||||
| Revenue growth | β13.1% | 12.9% | 2.5% | 2.1% | β6.3% | 18.3% | β0.8% | β2.0% | 0.8% | 4.5% |
| Net income growth | β41.5% | 59.5% | β29.7% | 18.9% | 0.8% | 64.4% | β5.2% | β0.8% | 155.2% | β59.4% |
| EPS growth | β40.5% | 58.5% | β27.2% | 22.9% | 2.0% | 64.7% | β4.1% | 1.4% | 158.6% | β59.2% |
| FCF growth | β25.1% | β4.3% | 8.6% | 22.7% | 23.8% | 0.6% | β37.0% | 93.9% | β20.2% | 21.5% |
| Share count change | β1.6% | 0.7% | β3.6% | β3.4% | β1.1% | β0.1% | β1.2% | β2.1% | β1.4% | β0.7% |
| Financial health | ||||||||||
| Net debt / EBITDA | 3.0x | 2.7x | 2.3x | 2.2x | 2.2x | 1.7x | 2.1x | 2.0x | 1.0x | 1.4x |
| Debt / equity | 0.9x | 0.8x | 1.1x | 1.0x | 0.9x | 0.7x | 0.9x | 0.7x | 0.5x | 0.6x |
| Interest coverage | 5.2x | 5.6x | 6.4x | 7.8x | 8.3x | 12.1x | 11.0x | 9.3x | 9.2x | 12.5x |
| Current ratio | 1.3x | 1.3x | 1.4x | 1.5x | 1.5x | 1.4x | 1.2x | 1.4x | 2.0x | 1.8x |
| Quick ratio | 0.9x | 1.0x | 1.0x | 1.0x | 1.0x | 0.8x | 0.7x | 0.9x | 1.5x | 1.3x |
| Capital allocation | ||||||||||
| Capex / revenue | 2.3% | 2.5% | 2.5% | 2.6% | 2.5% | 2.2% | 2.7% | 2.4% | 2.2% | 2.7% |
| Stock comp / revenue | 0.3% | 0.4% | 0.3% | 0.4% | 0.4% | 0.4% | 0.4% | 0.4% | 0.5% | 0.5% |
| Payouts / FCF | 45.0% | 68.3% | 190.6% | 56.1% | 41.6% | 32.7% | 146.7% | 24.7% | 85.1% | 73.7% |
| Quality scores | ||||||||||
| Piotroski F-score | 4.0 | 4.0 | 6.0 | 8.0 | 7.0 | 7.0 | 3.0 | 7.0 | 7.0 | 5.0 |
| Altman Z'' | 4.1 | 4.2 | 4.8 | 5.0 | 5.0 | 5.0 | 4.9 | 5.3 | 6.7 | 6.4 |
| Accruals ratio | β2.4% | 0.7% | β2.3% | β3.1% | β4.7% | 0.1% | 2.4% | β2.5% | 13.5% | β1.9% |
Source: SEC EDGAR XBRL filings (CIK 0000029905). Data updated October 22, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.